Navigation Links
Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
Date:1/26/2009

ROCKVILLE, Md., Jan. 26 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) today announced that it has received Official Notice of Allowance for its patent application, number 10/047,352, for Stable Neural Stem Cell Lines from the US Patent and Trade Office (USPTO). This patent covers the technology to immortalize any human neural stem cell, rendering its growth robust and long-lasting.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO)

"We are pleased to have received the Notice of Allowance on this important technology," said President & CEO Richard Garr. "The technology behind this patent allows us to grow practically unlimited quantities of neural stem cells from all regions of the brain without regard to the natural mitotic (growth) limits of cells from a particular region. Equally important, this technology is a next-generation immortalization process that avoids the harmful effects of traditional immortalization methods, which have invariably resulted in uncontrolled growth. Our technology provides the necessary assurance that the cell lines are fully controlled and remain consistent trial-over-trial and year-after-year. This consistency is ultimately key to the commercialization of any cell products and greatly enhances our ability to deliver cell therapies for very prevalent diseases, such as stroke and traumatic brain injury. It will also enable, for the first time, systematic drug screening against many different kinds of normal human brain cells for new Central Nervous System (CNS) drugs, and stem cell-mediated protein delivery for neurologic diseases."

About the Technology

The newly patented method uses cMyc-ER, a recombinant fusion of two proteins normally present in cells, c-Myc, a human cell-cycle regulating protein, and estrogen receptor (ER), a human protein that is activate
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related biology technology :

1. Neuralstem Shares Accepted for Trading on Amex(R)
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Neuralstem Sues StemCells, Inc. Over New Patent
6. Neuralstem Responds to New StemCells, Inc. Lawsuit
7. Neuralstem Fills Key Product Development Position
8. Neuralstem Reports Second Quarter Financial Results and Highlights
9. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...
(Date:12/1/2009)... Congruent Software agree...including project accounting clients) to Synergy B... Seattle, WA (PRWEB) Decemb... today it has acquired the Microsoft Dynamics SL p...ness technology provider. The move was necessary d...
(Date:12/1/2009)..., , INDIANAPOLIS and NORTH VANCOUVER, Bri...w AgroSciences LLC, a wholly owned subsidiary of T...ma Biosciences, Inc. today announced the signing o...nt. The agreement provides Dow AgroSciences with a...oci (ETL) technology on an exclusive basis in majo...
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCal...X) (the "Company"), an Atlanta-based, biopharmaceu...es caused by HIV-1 (Human Immunodeficiency Virus) ...upport for World AIDS Day. ,, "Today is the 21s...hat have lost their fight with the HIV/AIDS pandem...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
...PAIGN, Ill. A team of researchers at the Universi...lassical Newtonian mechanics, an entire collection...rconducting wire is able to "tunnel" as a pack fro...with a notably lower current, providing more evide...ling. , Physics professors Alexey Bezryadin and P...
...OSS, Ga., May 27 Immucor, Inc. (Nasdaq: BLUD ),...-reagent systems to the blood transfusion industry...greement with Alverno Clinical Laboratories, LLC, ...tegrated delivery systems in the nation, serving 2...he agreement, Alverno is standardizing pre-transfu...
...EW YORK, May 27 /PRNewswire-Asia-FirstCall/ -- Bio...ny") (OTC Bulletin Board: BSPM) today reported,fin..., 2009. , The Company reported revenue of $7,4...ared to $6,810,259 during the first quarter of 200...9,032, or $0.08 per share on a fully,diluted basis...
Other Biology Technology:Evidence of macroscopic quantum tunneling detected in nanowires 2Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement 2Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 2Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 3Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 4Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 5Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 6
(Date:12/1/2009)...apsed video of individual breast tissue cells reve...l: a protein that cycles between two major compart...more complete view of the internal signals that ca...ry in cancer and are targets of drug development. ... growth factors, travels back and forth between th...
(Date:11/30/2009)...w of the state of Antarctica,s climate and its rel...d this week (Tuesday 1 December) by the Scientific...ew - Antarctic Climate Change and the Environment ...nt, identifies areas for future scientific researc...makers have about Antarctic melting, sea-level ris...
(Date:11/30/2009)... German . , The DFG has approved the establ...s of 1 January 2010. This decision was made recent...ew centres will initially be funded for four years...ent overhead funding for indirect costs will also ...h topics range from modern prostheses to political...
Breaking Biology News(10 mins):ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4First comprehensive review of the state of Antarctica's climate 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Strangers Cell Phone Ring May Thwart Your Thinking 47902 1Strangers Cell Phone Ring May Thwart Your Thinking 47902 2Strangers Cell Phone Ring May Thwart Your Thinking 47902 3Medivation to Present at 8th Annual Needham Life Sciences Conference 47901 1Medivation to Present at 8th Annual Needham Life Sciences Conference 47901 2Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 1Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 2Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 3Health Care Finance to Implement Districts First Medicaid Patient Data Hub Using MedPlus Technology 47898 4
...medication appears to halt the production of an en..., a new study using tissue cultures suggests. , Th...ents on breast cancer cells, scientists found that...of aromatase, the enzyme implicated in estrogen-de...is the most common kind of breast cancer in postme...
...ime, ecologists have been able to show that molecu... a population in its natural habitat. Research Pro...r Ilik Saccheri, University of Liverpool, UK, disc... fritillary butterfly (Melitaea cinxia) is affecte... isomerase (Pgi) enzyme. The result challenges pre...
... sequenced and compared the genomes of planktonic ... Pacific Ocean. The pioneering study yielded insig...s at each depth--ranging from 40 to more than 13,0...he genomes of entire microbial communities, we can...em," said MIT,s Ed DeLong, who led the research te...
Other Biology News:Pain killer fights breast cancer by targeting key enzyme 2Pain killer fights breast cancer by targeting key enzyme 3New discovery: Molecular variation in one gene affects the growth of natural populations 2Wyoming cloud seeding experiment begins this month 2Wyoming cloud seeding experiment begins this month 3
Anti-Human Apolipoprotein B100 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Anti-Mouse Ameloblastin Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Goat Anti-Human SOST Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human CDC23 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: